These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2262911)

  • 1. Selective blockade of angiotensin responses in the rabbit isolated vas deferens by angiotensin receptor antagonists.
    Trachte GJ; Ferrario CM; Khosla MC
    J Pharmacol Exp Ther; 1990 Dec; 255(3):929-34. PubMed ID: 2262911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological differentiation of angiotensin effects in the rabbit isolated vas deferens with dithiothreitol and pertussis toxin.
    Trachte GJ
    J Pharmacol Exp Ther; 1990 Apr; 253(1):80-4. PubMed ID: 2158555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha adrenergic receptors mediate angiotensin-induced prostaglandin production in the rabbit isolated vas deferens.
    Trachte GJ; Stein E; Peach MJ
    J Pharmacol Exp Ther; 1987 Feb; 240(2):433-40. PubMed ID: 3027311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of angiotensin receptors mediating the neuromodulatory effects of angiotensin in the vas deferens of the rabbit.
    Hegde SS; Clarke DE
    J Pharmacol Exp Ther; 1993 May; 265(2):601-8. PubMed ID: 8496811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent.
    Chiu AT; McCall DE; Price WA; Wong PC; Carini DJ; Duncia JV; Wexler RR; Yoo SE; Johnson AL; Timmermans PB
    J Pharmacol Exp Ther; 1990 Feb; 252(2):711-8. PubMed ID: 2313596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonpeptide angiotensin II receptor antagonists: insurmountable angiotensin II antagonism of EXP3892 is reversed by the surmountable antagonist DuP 753.
    Wong PC; Timmermans PB
    J Pharmacol Exp Ther; 1991 Jul; 258(1):49-57. PubMed ID: 2072311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diversified pharmacology of angiotensin II-receptor blockade.
    Timmermans PB; Smith RD
    Blood Press Suppl; 1996; 2():53-61. PubMed ID: 8913541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of angiotensin receptor blockade in the rabbit aorta: influence of the endothelium.
    le Tran Y; Forster C
    Can J Physiol Pharmacol; 1996 Dec; 74(12):1277-86. PubMed ID: 9047036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine receptor antagonism attenuates angiotensin II effects on adrenergic neurotransmission in the rabbit isolated vas deferens.
    Trachte GJ; Heller LJ
    J Pharmacol Exp Ther; 1990 May; 253(2):490-6. PubMed ID: 2159994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenergic nerves mediate angiotensin-induced prostaglandin release in the rabbit vas deferens.
    Trachte GJ
    J Pharmacol Exp Ther; 1988 Jul; 246(1):211-7. PubMed ID: 3392653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of [3H]LF 7-0156, a new nonpeptide antagonist radioligand for the type 1 angiotensin II receptor.
    Nouet S; Dodey P; Renaut P; Marie J; Pruneau D; Larguier R; Lombard C; Bonnafous JC
    Mol Pharmacol; 1994 Oct; 46(4):693-701. PubMed ID: 7969048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the specific angiotensin II receptor antagonist losartan on urate homeostasis and intestinal urate transport.
    Hatch M; Freel RW; Shahinfar S; Vaziri ND
    J Pharmacol Exp Ther; 1996 Jan; 276(1):187-93. PubMed ID: 8558429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II receptors and angiotensin II receptor antagonists.
    Timmermans PB; Wong PC; Chiu AT; Herblin WF; Benfield P; Carini DJ; Lee RJ; Wexler RR; Saye JA; Smith RD
    Pharmacol Rev; 1993 Jun; 45(2):205-51. PubMed ID: 8372104
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II receptor inhibition. A new therapeutic principle.
    Messerli FH; Weber MA; Brunner HR
    Arch Intern Med; 1996 Sep; 156(17):1957-65. PubMed ID: 8823149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta adrenoceptor blockade in rabbit inhibits the renin-releasing effect of AT1 receptor antagonist losartan.
    Hajj-Ali AF; Wong PC
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1423-7. PubMed ID: 7903389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial natriuretic factor inhibits adrenergic and purinergic neurotransmission in the rabbit isolated vas deferens.
    Drewett JG; Trachte GJ; Marchand GR
    J Pharmacol Exp Ther; 1989 Jan; 248(1):135-42. PubMed ID: 2536425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hormonal contribution to short-term variability of blood pressure in a renovascular hypertension model].
    Ponchon P; Elghozi JL
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1203-7. PubMed ID: 8572874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensins induce the release of prostacyclin from rabbit vas deferens: evidence for receptor heterogeneity.
    Catalioto RM; Renzetti AR; Criscuoli M; Mizrahi J; Subissi A
    Eur J Pharmacol; 1994 Apr; 256(1):93-7. PubMed ID: 8026565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin peptides and prostaglandin E2 synthesis: modulation of neurogenic responses in the rabbit vas deferens.
    Saye J; Binder SB; Trachte GJ; Peach MJ
    Endocrinology; 1986 Nov; 119(5):1895-903. PubMed ID: 3464412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.